Cargando…

A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2

Detalles Bibliográficos
Autores principales:	Vitale, Emanuele, Sauta, Elisabetta, Gugnoni, Mila, Torricelli, Federica, Manicardi, Veronica, Ciarrocchi, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456690/ https://www.ncbi.nlm.nih.gov/pubmed/35451571 http://dx.doi.org/10.1002/cac2.12292

Ejemplares similares

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
por: Gugnoni, Mila, et al.
Publicado: (2022)

HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
por: Manzotti, Gloria, et al.
Publicado: (2019)

KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)
por: Lorenzini, Eugenia, et al.
Publicado: (2022)

No Need to Stick Together to Be Connected: Multiple Types of Enhancers’ Networking
por: Vitale, Emanuele, et al.
Publicado: (2021)

An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization
por: Torricelli, Federica, et al.
Publicado: (2023)

Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7
por: Gugnoni, Mila, et al.
Publicado: (2023)

RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
por: Sancisi, Valentina, et al.
Publicado: (2017)

Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer
por: Gugnoni, Mila, et al.
Publicado: (2019)

An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
por: Reggiani, Francesca, et al.
Publicado: (2021)

The DNA-helicase HELLS drives ALK(−) ALCL proliferation by the transcriptional control of a cytokinesis-related program
por: Tameni, Annalisa, et al.
Publicado: (2021)

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
por: Rossi, Teresa, et al.
Publicado: (2023)

Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma
por: Mularoni, Valentina, et al.
Publicado: (2023)

Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
por: Gugnoni, Mila, et al.
Publicado: (2016)

The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1
por: Gallo, Cristina, et al.
Publicado: (2018)

Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas
por: Gandolfi, Greta, et al.
Publicado: (2017)

Addiction to RUNX in lymphoma
por: Neil, James C., et al.
Publicado: (2016)

The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling
por: Gobbi, Giulia, et al.
Publicado: (2023)

Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic Alterations
por: Lorenzini, Eugenia, et al.
Publicado: (2021)

Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy
por: Torricelli, F, et al.
Publicado: (2023)

Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinoma
por: Piana, Simonetta, et al.
Publicado: (2019)

CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
por: Sauta, Elisabetta, et al.
Publicado: (2021)

Cadherin 6 Is a New RUNX2 Target in TGF-β Signalling Pathway
por: Sancisi, Valentina, et al.
Publicado: (2013)

The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle
por: Rigillo, Giovanna, et al.
Publicado: (2021)

Telomerase and Telomeres Biology in Thyroid Cancer
por: Donati, Benedetta, et al.
Publicado: (2019)

Hemophagocytic Lymphohistiocytosis in RUNX1::RUNX1T1 Positive AML with Blast Count Below 20%
por: Huang, Xingqin, et al.
Publicado: (2023)

BET inhibition prevents aberrant RUNX1 and ERG transcription in STAG2 mutant leukaemia cells
por: Antony, Jisha, et al.
Publicado: (2020)

The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy
por: Homan, Claire C., et al.
Publicado: (2021)

Epigenetic Regulation of RUNX3 in Thyroid Carcinoma
por: Joung, Kyong Hye, et al.
Publicado: (2012)

Runx transcription factors in neuronal development
por: Inoue, Ken-ichi, et al.
Publicado: (2008)

Not the same thing: metastatic PTCs have a different background than ATCs
por: de Biase, Dario, et al.
Publicado: (2018)

Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes
por: Ogawa, Eisaku, et al.
Publicado: (2022)

The First Case of Acute Myeloid Leukemia With a Novel Five-way Variant Translocation of RUNX1–RUNX1T1
por: Jo, Yong Hun, et al.
Publicado: (2023)

Co-existence of RUNX1-RUNX1T1 and BCR-ABL1 in acute myeloid leukemia: a case report
por: Park, Suji, et al.
Publicado: (2023)

BRD4 and Cancer: going beyond transcriptional regulation
por: Donati, Benedetta, et al.
Publicado: (2018)

DNA Methylation of RUNX3 in Papillary Thyroid Cancer
por: Ko, Hee Ja, et al.
Publicado: (2012)

Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
por: Ragazzi, Moira, et al.
Publicado: (2014)

A Bayesian data fusion based approach for learning genome-wide transcriptional regulatory networks
por: Sauta, Elisabetta, et al.
Publicado: (2020)

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
por: Illendula, Anuradha, et al.
Publicado: (2016)

RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia
por: Grinev, Vasily V., et al.
Publicado: (2021)

Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin
por: Cortini, Margherita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4160seb83c981sfc7ovfri1plm